Literature DB >> 7032205

Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel.

L Truedsson, A G Sjöholm, A B Laurell.   

Abstract

Two assays based on hemolysis in gel were assessed for screening complement (C) component deficiencies. In one assay sensitized sheep erythrocyte (EA) were incorporated in agarose gel containing Ca2+ and Mg2+, in the other guinea pig erythrocytes (GpE) were used in the presence of Mg2+and EGTA. With few exceptions, fresh samples from healthy individuals produced homogeneous areas of complete hemolysis in both assays. Clearly aberrant patterns were observed in approximately 4% of healthy blood donors. Sera from patients having complete deficiencies of Clq, C2 or C4 produced clear lysis of GpE only, whereas in sera lacking C3 or C8 lysis was grossly impaired in both assays. Properdin deficient serum produced very slight lysis of GpE but normal lysis of EA. Reconstitution of these C-deficient sera gave normal lysis. Together, the two assays supplement immunochemical C3 and C4 determinations for screening out C disorders.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7032205     DOI: 10.1111/j.1699-0463.1981.tb02680.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  15 in total

1.  Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.

Authors:  B Selander; H Käyhty; E Wedege; E Holmström; L Truedsson; C Söderström; A G Sjöholm
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n).

Authors:  P J Späth; A G Sjöholm; G N Fredrikson; G Misiano; R Scherz; U B Schaad; B Uhring-Lambert; G Hauptmann; J Westberg; M Uhlén; C Wadelius; L Truedsson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.

Authors:  C G Becker; M Wagner; A P Kaplan; M Silverberg; R W Grady; H Liem; U Muller-Eberhard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Properdin deficiency in a family with fulminant meningococcal infections.

Authors:  A G Sjöholm; J H Braconier; C Söderström
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

5.  Investigation for complement deficiency following meningococcal disease.

Authors:  S Hoare; O El-Shazali; J E Clark; A Fay; A J Cant
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

6.  Presence of serum modulates expression of complement receptor type 1 (CR1) on human granulocytes after quartz exposure.

Authors:  J Lundahl; A Eklund; J Hed; G Tornling; M Vitas
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

7.  Inherited complement deficiency in children surviving fulminant meningococcal septic shock.

Authors:  H H Derkx; E J Kuijper; C A Fijen; M Jak; J Dankert; S J van Deventer
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

8.  Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.

Authors:  O Nived; C Linder; H Odeberg; B Svensson
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

9.  Effect of sulfide ions on complement factor C3.

Authors:  M Granlund-Edstedt; E Johansson; R Claesson; J Carlsson
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency.

Authors:  C A Fijen; B H Derkx; E J Kuijper; M Mannens; S R Poort; M Peters; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.